Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATP6V0E1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RDH11 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
PTK2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
MLYCD - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
UQCR11 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
SLC19A1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
DSCR3 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
THADA - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
UPF1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
SMARCA4 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GID8 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
LPXN - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
MIR6758 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
NFYC - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
AKAP13 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
SLC35F2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
ADAM17 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
DCTD - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
G6PD - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
STAM - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on